Edition:
United Kingdom

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

3.14USD
7:41pm BST
Change (% chg)

$-0.04 (-1.26%)
Prev Close
$3.18
Open
$3.15
Day's High
$3.17
Day's Low
$3.11
Volume
21,150
Avg. Vol
110,692
52-wk High
$5.82
52-wk Low
$1.59

Latest Key Developments (Source: Significant Developments)

HTG Molecular Diagnostics Inc Says On March 30, 2018, Co And Qiagen Manchester Limited Entered Second Amendment Of First Statement Of Work
Wednesday, 4 Apr 2018 

April 5 (Reuters) - HTG Molecular Diagnostics Inc :HTG MOLECULAR DIAGNOSTICS INC - ON MARCH 30, 2018, CO AND QIAGEN MANCHESTER LIMITED ENTERED SECOND AMENDMENT OF FIRST STATEMENT OF WORK - SEC FILING.HTG MOLECULAR DIAGNOSTICS INC - QIAGEN HAS AGREED TO PAY COMPANY LOW, SINGLE-DIGIT MILLIONS OF DOLLARS IN DEVELOPMENT FEES FOR NEXT-PHASE ACTIVITIES.HTG- QIAGEN ALSO AGREED TO PAY CO MILESTONE UPTO AMOUNT IN LOW,SINGLE-DIGIT MLN OF DOLLARS ON ACHIEVEMENT OF SOME MILESTONES IN NEXT-PHASE ACTIVITIES.HTG MOLECULAR DIAGNOSTICS INC - THE NEXT-PHASE ACTIVITIES ARE EXPECTED TO BE COMPLETED IN Q2 OF 2018.  Full Article

Stonepine Capital Management Reports 5.6 Pct Passive Stake In HTG Molecular Diagnostics
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Htg Molecular Diagnostics Inc ::STONEPINE CAPITAL MANAGEMENT LLC REPORTS A 5.6 PERCENT PASSIVE STAKE IN HTG MOLECULAR DIAGNOSTICS INC AS OF JANUARY 19 - SEC FILING.  Full Article

HTG Molecular Diagnostics Announces Pricing Of Public Offering Of Common Stock
Friday, 19 Jan 2018 

Jan 18 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 12.1 MILLION COMMON SHARES PRICED AT $2.90PER SHARE.  Full Article

HTG Molecular Diagnostics Intends To Offer 10 mln shares of common stock
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.HTG MOLECULAR DIAGNOSTICS - ‍INTENDS TO OFFER AND SELL, 10 MILLION SHARES OF COMMON STOCK IN UNDERWRITTEN PUBLIC OFFERING​.  Full Article

HTG Announces Preliminary Q4 And Full Year 2017 Unaudited Financial Results
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - HTG Molecular Diagnostics Inc ::HTG ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 UNAUDITED FINANCIAL RESULTS AND PROVIDES INITIAL 2018 REVENUE GUIDANCE.SEES Q4 2017 REVENUE $6.9 MILLION TO $7.2 MILLION.SEES FY 2017 REVENUE $13.8 MILLION TO $14.1 MILLION.SEES FY 2018 REVENUE $20 MILLION TO $25 MILLION.  Full Article

HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement
Wednesday, 27 Dec 2017 

Dec 27 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT.HTG MOLECULAR DIAGNOSTICS SAYS UNDER PLAN, ILLUMINA EXPECTED TO DEVELOP & DELIVER TO CO EXECUTABLE VERSION OF CUSTOM SOFTWARE - SEC FILING.  Full Article

HTG Molecular Diagnostics Expands Its Collaboration With Merck
Tuesday, 26 Dec 2017 

Dec 26 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS EXPANDS ITS COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY.HTG MOLECULAR - TO DEVELOP CUSTOM PROFILING ASSAY TO SUPPORT BIOMARKER RESEARCH FOR 6 INDICATIONS WITHIN MERCK KGAA'S DRUG DEVELOPMENT PIPELINE.  Full Article

HTG Molecular Diagnostics And Unit Of QIAGEN Amended First Statement Of Work Under Master Agreement
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC. 18. CO, UNIT OF QIAGEN, AMENDED FIRST STATEMENT OF WORK UNDER MASTER AGREEMENT - SEC FILING.HTG MOLECULAR DIAGNOSTICS - UNDER AGREEMENT, QIAGEN AGREED TO PAY CO LOW, SINGLE‑DIGIT MILLIONS OF DOLLARS FOR NEXT‑PHASE ACTIVITIES FOR PROJECT.  Full Article

HTG Molecular Diagnostics reports third quarter earnings
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports 2017 third quarter earnings.Q3 loss per share $0.46.Sees FY 2017 revenue $10 million to $13 million.Q3 revenue $3.7 million.  Full Article

HTG Molecular Diagnostics Q2 loss per share $0.98
Tuesday, 9 Aug 2016 

Htg Molecular Diagnostics Inc : Q2 loss per share $0.98 . Htg molecular diagnostics reports second quarter 2016 results .Q2 revenue rose 140 percent to $1.9 million.  Full Article

BRIEF-HTG Molecular Diagnostics Gets Notice From Qiagen Manchester

* HTG MOLECULAR DIAGNOSTICS SAYS RECEIVED NOTICE FROM QIAGEN MANCHESTER LTD THAT QIAGEN ENDED FIRST STATEMENT OF WORK, DATED JUNE 14, 2017 - SEC FILING Source text: (https://bit.ly/2rW1VKY) Further company coverage: